Library — CHDR

Search

Filter

Effect profile of paracetamol, Δ9-THC and promethazine using an evoked pain test battery in healthy subjects.

van Amerongen G, Siebenga P, de Kam ML, Hay JL, Groeneveld GJ

European journal of pain (London, England), 2018 Aug; 22(7):1331-1342

View publication
Evaluating Fitness to Perform in Surgical Residents after Night Shifts and Alcohol Intoxication: The development of a "Fit-to-Perform" test.

Huizinga CRH, de Kam ML, Stockmann HBAC, van Gerven JMA, Cohen AF, van der Bogt KEA

Journal of surgical education, 2018 Jul; 75(4):968-977

View publication
Complement Activation in Inflammatory Skin Diseases.

Giang J, Seelen MAJ, van Doorn MBA, Rissmann R, Prens EP, Damman J

Frontiers in immunology, 2018 Jul

View publication
Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development.

van der Kolk T, Assil S, Rijneveld R, Klaassen ES, Feiss G, Florencia E, Prens EP, Burggraaf J, Moerland M, Rissmann R, van Doorn MBA

Clinical and translational science, 2018 Jul

View publication
Rifampin levels in daily practice: the accuracy of a single measurement.

Vanbrabant TJF, Dijkmans AC, den Hartigh J, Touw DJ, Arend SM

The Netherlands journal of medicine, 2018 Jul; 76(5):235-242

View publication
Subanesthetic Dose Ketamine in Posttraumatic Stress Disorder: A Role for Reconsolidation During Trauma-Focused Psychotherapy?

Veen C, Jacobs G, Philippens I, Vermetten E

Current topics in behavioral neurosciences, 2018 Jun

View publication
GSH-PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first-in-human study.

Kanhai KMS, Zuiker RGJA, Stavrakaki I, Gladdines W, Gaillard PJ, Klaassen ES, Groeneveld GJ

British journal of clinical pharmacology, 2018 May

View publication
Futility of current urine salbutamol doping control.

Heuberger JAAC, van Dijkman SC, Cohen AF

British journal of clinical pharmacology, 2018 May

View publication
Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products (EMEA/CHMP/SWP/28367/07 Rev. 1.

van Gerven J, Bonelli M

British journal of clinical pharmacology, 2018 May

View publication

«
1
2
...
5
6
7
8
9
10
11
...
64
65
»